X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 45 filers reported holding X4 PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,737 | -43.8% | 61,227 | 0.0% | 0.00% | – |
| Q2 2023 | $118,780 | +32.0% | 61,227 | +486.5% | 0.00% | – |
| Q1 2021 | $90,000 | +23.3% | 10,439 | -8.5% | 0.00% | – |
| Q4 2020 | $73,000 | +32.7% | 11,411 | +39.6% | 0.00% | – |
| Q3 2020 | $55,000 | -22.5% | 8,172 | +7.5% | 0.00% | – |
| Q2 2020 | $71,000 | +26.8% | 7,600 | +36.3% | 0.00% | – |
| Q1 2020 | $56,000 | -28.2% | 5,577 | -24.9% | 0.00% | – |
| Q4 2019 | $78,000 | +66.0% | 7,426 | +94.0% | 0.00% | – |
| Q3 2019 | $47,000 | -39.7% | 3,827 | -27.4% | 0.00% | – |
| Q2 2019 | $78,000 | +13.0% | 5,272 | +30.1% | 0.00% | – |
| Q1 2019 | $69,000 | – | 4,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |